Diabetes management in obesity medicine becomes especially complex when compounded by advanced complications such as kidney disease, cardiovascular disease, and neuropathy. This lecture emphasizes high-stake scenarios where standard therapies may be contraindicated, dosing must be individualized, and risks of hypoglycemia or adverse drug events are magnified. Case-oriented teaching will explore strategies for balancing obesity therapies, diabetes medications, and comorbidity management in fragile patients. Attendees will gain the tools to navigate “gray zones” where guideline recommendations leave gaps.

CME/CE Expiration Date: 4/9/29

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.